286 THE NOVEL FC-ENGINEERED CD33 ANTIBODY BI 836858 IMPROVES HEMATOPOIESIS BY PROTECTING HSC/HPC FROM ROS-MEDIATED DNA DAMAGE IN MDS. Issue 1 (April 2015) - Eksioglu, E.A.; Chen, X.; Heider, K.H.; Rueter, B.; Burnette, A.; Wei, M.; McGraw, K.; Liu, J.; Basiorka, A.; Patel, P.; Lancet, J.; Komrokji, R.; et al.